Silk Road Medical, Inc SILK
$ 27.49
0.0%
Quarterly report 2024-Q2
added 08-07-2024
Silk Road Medical, Inc Balance Sheet 2011-2024 | SILK
Annual Balance Sheet Silk Road Medical, Inc
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
57.1 M | 21.1 M | -64.4 M | -20.4 M | 57.2 M | 19.2 M | -5.74 M | - | - | - | - | - | - |
Long Term Debt |
75.6 M | 74.6 M | 44.8 M | 48.5 M | 44.9 M | 44.2 M | 27.6 M | - | - | - | - | - | - |
Long Term Debt Current |
1.7 M | 1.84 M | 1.29 M | 850 K | 769 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 48.6 M | 45.3 M | 137 M | - | - | - | - | - | - |
Total Current Liabilities |
30.3 M | 24.5 M | 26.1 M | 19.6 M | 16.9 M | - | - | - | - | - | - | - | - |
Total Liabilities |
114 M | 106 M | 77.4 M | 71.8 M | 65.5 M | 54.1 M | 142 M | - | - | - | - | - | - |
Deferred Revenue |
256 K | 249 K | 157 K | 206 K | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-399 M | -344 M | -289 M | -239 M | -192 M | -139 M | -102 M | - | - | - | - | - | - |
Total Assets |
265 M | 270 M | 157 M | 179 M | 137 M | 40.9 M | 43.1 M | - | - | - | - | - | - |
Cash and Cash Equivalents |
20.2 M | 55.4 M | 110 M | 69.8 M | 39.2 M | 25.3 M | 33.8 M | - | - | - | - | - | - |
Book Value |
151 M | 164 M | 79.2 M | 108 M | 71.9 M | -13.2 M | -98.6 M | - | - | - | - | - | - |
Total Shareholders Equity |
151 M | 164 M | 79.2 M | 108 M | 71.9 M | -135 M | -98.6 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Silk Road Medical, Inc
2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
76.1 M | 75.9 M | 75.6 M | 75.4 M | 75.1 M | 74.8 M | 74.6 M | 74.3 M | 74 M | 38.9 M | 44.8 M | 48.7 M | 48.6 M | 48.6 M | 48.5 M | 48.5 M | 48.5 M | 48.5 M | 44.9 M | 44.9 M | 44.9 M | 44.9 M | 44.2 M | 44.2 M | 44.2 M | 44.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
115 M | 105 M | 114 M | 108 M | 108 M | 102 M | 106 M | 105 M | 103 M | 75.3 M | 77.4 M | 77.4 M | 72.1 M | 68.5 M | 71.8 M | 71.8 M | 71.8 M | 71.8 M | 65.5 M | 65.5 M | 65.5 M | 65.5 M | 72.1 M | 70.2 M | 70.2 M | 70.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
270 K | 317 K | 143 K | 120 K | 220 K | 209 K | 253 K | 298 K | 482 K | 522 K | 157 K | 448 K | 478 K | 536 K | 206 K | 206 K | 206 K | 206 K | 304 K | 304 K | 304 K | 304 K | 137 K | 137 K | 137 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-430 M | -414 M | -399 M | -386 M | -374 M | -360 M | -344 M | -331 M | -321 M | -305 M | -289 M | -274 M | -260 M | -250 M | -239 M | -239 M | -239 M | -239 M | -192 M | -192 M | -192 M | -192 M | -139 M | -139 M | -139 M | -139 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
270 M | 252 M | 265 M | 261 M | 263 M | 260 M | 270 M | 163 M | 163 M | 143 M | 157 M | 166 M | 168 M | 170 M | 179 M | 179 M | 179 M | 179 M | 137 M | 137 M | 137 M | 137 M | 42.7 M | 40.9 M | 40.9 M | 40.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
22.6 M | 22.6 M | 20.2 M | 29.2 M | 28.4 M | 50.6 M | 55.4 M | 51.5 M | 87.9 M | 93.8 M | 110 M | 106 M | 102 M | 94.6 M | 69.8 M | 69.5 M | 69.5 M | 69.5 M | 39.2 M | 39.2 M | 39.2 M | 39.2 M | 25 M | 25 M | 25 M | 25 M | 33.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
155 M | 147 M | 151 M | 153 M | 156 M | 158 M | 164 M | 57.2 M | 60 M | 67.7 M | 79.2 M | 88.2 M | 96.1 M | 101 M | 108 M | 108 M | 108 M | 108 M | 71.9 M | 71.9 M | 71.9 M | 71.9 M | -29.3 M | -29.3 M | -29.3 M | -29.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
155 M | 147 M | 151 M | 153 M | 156 M | 158 M | 164 M | 57.2 M | 60 M | 67.7 M | 79.2 M | 88.2 M | 96.1 M | 101 M | 108 M | 108 M | 108 M | 108 M | 71.9 M | 71.9 M | 71.9 M | 71.9 M | -135 M | -135 M | -135 M | -135 M | -98.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency